EMVision Medical Devices (ASX:EMV) has established its pilot commercial production line and received the final $1,250,000 non-dilutive cash payment under the Modern Manufacturing Initiative (MMI) grant programme.
EMVision was awarded $5 million in non-dilutive funding under the Federal Government's MMI Medical Products Translation stream to establish commercial production of EMVision's emu point-of-care brain scanner.
The production line, at EMVision’s Macquarie Park premises, has an initial capacity for the build, test and release of approximately one emu brain scanner per week. With modest personnel additions, under its current configuration, the production line is anticipated to have capacity for the build, test and release of up to three emu brain scanner devices per week.
EMVision is developing a novel approach to looking inside the human body. Its product pipeline includes portable, non- invasive, affordable and safe neuroimaging devices.
